• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SISTEMAS MEDICOS ALARIS S.A. DE C.V. BD ALARIS SMARTSITE EXTENSION SET; INTRAVASCULAR ADMINISTRATION SET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SISTEMAS MEDICOS ALARIS S.A. DE C.V. BD ALARIS SMARTSITE EXTENSION SET; INTRAVASCULAR ADMINISTRATION SET Back to Search Results
Catalog Number 10012866
Medical Device Problem Codes Backflow (1064); Fluid/Blood Leak (1250)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 01/15/2026
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
H.3.If a device evaluation and/or device history review is completed, a supplemental report will be filed.
 
Event or Problem Description
It was reported that bd alaris extension set was damaged the following information was received by the initial reporter with the following verbatim.It was reported by customer that there was blood backed up into tpn line, all the way to the tpn filter.I also noticed the filter itself was sticky to the touch around the 2 white circles on the flat side of the filter, which tpn is very sticky when spilled so this almost certainly is tpn leaking.There were no wet spots in the patient¿s bed, or on the floor of fluid leaking.I called the cn to look at the line, and she agreed that i should change the filter, flush the trifuse, and restart the tpn.I did so, and the line flushed perfectly so i attached a new filter to the tpn line and restarted the infusion.I had given another iv medication at ~0300, and the line had looked like normal.So, the filter failed in between 0300 and 0400.This makes me think the filter was faulty because it was leaking tpn.
 
Additional Manufacturer Narrative
Investigation summary: one sample was returned for investigation.The set was examined for defects and abnormalities.No defects or abnormalities were observed.The set was flushed with water and a leak was observed coming from both vents of the filter.The set was laid out to dry and an air under water pressure test was performed.The hydrophobicity of both vents was restored.The likely cause of the leakage was the drug used in the set caused the membranes to lose their hydrophobicity properties.
 
Event or Problem Description
No additional information.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD ALARIS SMARTSITE EXTENSION SET
Common Device Name
INTRAVASCULAR ADMINISTRATION SET
Manufacturer (Section D)
SISTEMAS MEDICOS ALARIS S.A. DE C.V.
blvd. insurgentes no. 20351
parque industrial el florido
tijuana
Manufacturer (Section G)
SISTEMAS MEDICOS ALARIS, S.A. DE C.V.
blvd. insurgentes no. 20351
parque industrial el florido
tijuana
Manufacturer Contact
helen cox (mdr)
75 north fairway drive
vernon hills, IL 60061
8473935694
MDR Report Key24281743
Report Number9616066-2026-00241
Device Sequence Number15903450
Product Code FPA
UDI-Device Identifier10885403233777
UDI-Public(01)10885403233777
Combination Product (Y/N)N
Initial Reporter StateUT
Initial Reporter CountryUS
PMA/510(K) Number
K790108
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source User Facility
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 03/25/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Other
Device Catalogue Number10012866
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 01/20/2026
Supplement Date Received by Manufacturer03/25/2026
Initial Report FDA Received Date02/06/2026
Supplement Report FDA Received Date04/11/2026
Was Device Evaluated by Manufacturer? (Y/N) Yes
Is the Device Labeled for Single Use? (Y/N) Yes
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-